Adjuvant enzalutamide (Enza) for men with high-risk prostate cancer (HRPCa) after radical prostatectomy (RP).

被引：0
|
作者：
Ornstein, Moshe Chaim
Stephenson, Andrew J.
Elson, Paul
Tyler, Allison Janine
Profusek, Pam
Grivas, Petros
Rini, Brian I.
Klein, Eric A.
Garcia, Jorge A.
机构：
[1] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
[2] Cleveland Clin, Glickman Urol & Kidney Inst, Cleveland, OH 44106 USA
[3] Cleveland Clin, Cleveland, OH 44106 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.5071
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5071
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Adjuvant enzalutamide (Enza) for men with non-metastatic high-risk prostate cancer (HRPCa) after radical prostatectomy (RP).
    Ornstein, Moshe Chaim
    Stephenson, Andrew J.
    Elson, Paul
    Tyler, Allison Janine
    Profusek, Pam
    Allman, Kimberly D.
    Barata, Pedro C.
    Magi-Galluzzi, Cristina
    Fergany, Amr Farouk
    Stein, Robert
    Fareed, Khaled
    Haber, Georges-Pascal
    Campbell, Steven C.
    Kaouk, Jihad
    Grivas, Petros
    Rini, Brian I.
    Klein, Eric A.
    Garcia, Jorge A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [2] AUO Adjuvant therapy in high-risk prostate cancer after radical prostatectomy
    Rexer, H.
    Boegemann, M.
    Graefen, M.
    UROLOGIE, 2022, 61 (06): : 705 - 706
  • [3] Adjuvant weekly docetaxel for high-risk prostate cancer patients after radical prostatectomy
    Kibel, AS
    Kattan, MW
    Picus, J
    Dreicer, R
    Klein, EA
    Wilding, G
    Jarrard, DF
    Roth, B
    Cookson, MS
    Pettylak, DP
    Chatta, G
    Nelson, JB
    Beer, TM
    Dipaola, R
    Partin, AI
    Rosenbaum, E
    Garrett, E
    Sugar, E
    Eisenberger, M
    JOURNAL OF UROLOGY, 2006, 175 (04): : 512 - 512
  • [4] Adjuvant weekly docetaxel for high-risk prostate cancer patients after Radical Prostatectomy
    Kibel, AS
    Picus, J
    Cookson, MS
    Roth, B
    Jarrard, DF
    Wilding, G
    Klein, EA
    Dreicer, R
    Nelson, JB
    Chatta, G
    Benson, MC
    Petrylak, DP
    DiPaola, R
    Beer, TM
    Diamond, J
    Partin, AW
    Eisenberger, MA
    JOURNAL OF UROLOGY, 2005, 173 (04): : 222 - 222
  • [5] Adjuvant chemotherapy and/or hormone therapy after radical prostatectomy for high-risk prostate cancer.
    Paule, B
    de la Taille, A
    PROGRES EN UROLOGIE, 2005, 15 (02): : 208 - 212
  • [6] Pilot trial of adjuvant paclitaxel (T) and estramustine phosphate (EMP) for high-risk prostate cancer patients after radical prostatectomy (RP).
    Lubiniecki, GM
    Malkowicz, SB
    Hendricks, M
    Bearn-Miranda, L
    van Arsdalen, K
    Wein, A
    Vaughn, DJ
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 446S - 446S
  • [7] Radical prostatectomy for high-risk prostate cancer
    Ofer Yossepowitch
    James A. Eastham
    World Journal of Urology, 2008, 26 : 219 - 224
  • [8] Radical prostatectomy for high-risk prostate cancer
    Yossepowitch, Ofer
    Eastham, James A.
    WORLD JOURNAL OF UROLOGY, 2008, 26 (03) : 219 - 224
  • [9] Radical Prostatectomy for High-risk Prostate Cancer
    Karnes, R. Jeffrey
    Hatano, Tadashi
    Blute, Michael L.
    Myers, Robert P.
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (01) : 3 - 9
  • [10] Radical prostatectomy in high-risk prostate cancer
    Ischia, Joseph
    Gleave, Martin
    INTERNATIONAL JOURNAL OF UROLOGY, 2013, 20 (03) : 290 - 300
12345